Cited by 202Antifungal resistance and susceptibilityFungal and yeast genetics researchDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate

Slaven, John W, Anderson, Michael J, Sanglard, Dominique, Dixon, Graham K, Bille, Jacques, Roberts, Ian S, Denning, David W·2002·Fungal Genetics and Biology

DOI 10.1016/s1087-1845(02)00016-6

Open this paper in CoChat — free account

Abstract

Aspergillus fumigatus is the most frequent causative agent of invasive aspergillosis. Itraconazole became available in 1990 to treat invasive aspergillosis, but instances of resistance have now been described. Drug efflux was a proposed mechanism in one itraconazole resistant clinical isolate (AF72) which accumulates low levels of the drug. Drug efflux in fungi can be mediated by ATP-binding cassette transporter (ABCT) genes, such as CDR1 in Candida albicans. Using a probe derived from CDR1, a gene, atrF, was cloned from A. fumigatus. The atrF gene product (AtrF) is 1547 amino acids long and has characteristic multidrug resistance motifs. Dot blot analysis revealed that AF72 has approximately 5-fold higher levels of atrF mRNA than susceptible isolates AF10 and H06-03 in cultures with sub-minimum inhibitory concentration (sub-MIC) levels of itraconazole. atrF is the first ABCT gene cloned from A. fumigatus, whose overexpression is correlated with itraconazole resistance.

Integrity signals

Registry

Crossref · 10.1016/s1087-1845(02)00016-6

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
Welsh, M. J., & Smith, A. E. (1993) · Cell · doi:10.1016/0092-8674(93)90353-r · Cited by 1,485
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Self-citation
Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital
Groll, A. H., Shah, P. M., MENTZEL, C., Schneider, M., Just‐Nübling, G., & Huebner, K. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)92700-0 · Cited by 777
Therapeutic Outcome in Invasive Aspergillosis
Denning, D. W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.608 · Cited by 683
Self-citation
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Self-citation
Itraconazole resistance in Aspergillus fumigatus
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 507
Self-citation
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Gene Structure in Eukaryotic Microbes
Kinghorn, J. R. (1987) · Medical Entomology and Zoology · Cited by 470

Show all 45 references

Research works printed but not linked: 1

Johnston, D., Cannom, R.R.M., Filler, S.G., 2000. Amino acid substitutions in the Aspergillus fumigatus ERG11 gene product render it resistant to itraconazole yet susceptibility to voriconazole is maintained. Abstract. Intersci. Conf. Antimicrob. Agents Chemother

Sorted by citations

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citation
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Self-citation
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Antifungal drug resistance: evolution, mechanisms and impact
Revie, N. M., Iyer, K. R., Robbins, N., & Cowen, L. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.005 · Cited by 552
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 531
A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations
Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 436
Self-citation
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis
Abad, A., Fernandez-Molina, J. V., Bikandi, J., Ramirez‐Garcia, A., Margareto, J., Sendino, J., Hernando, F. L., Pontón, J., Garaizar, J., & Rementerı́a, A. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.10.003 · Cited by 409
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
Bueid, A. S., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., & Denning, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq279 · Cited by 333
Self-citation
The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus
Fraczek, M. G., Bromley, M., Buied, A., Moore, C. B., Rajendran, R., Rautemaa‐Richardson, R., Ramage, G., Denning, D. W., & Bowyer, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt075 · Cited by 313
Self-citation
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285
Azole Resistance in Candida glabrata : Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor
Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285
A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus
Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints
Verweij, P. E., Howard, S. J., Melchers, W. J. G., & Denning, D. W. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.09.002 · Cited by 258
Self-citation
Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole
do Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., & Perlin, D. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1719-1726.2003 · Cited by 256
Aspergillus fumigatus and aspergillosis: From basics to clinics
Arastehfar, A. A., Carvalho, A., Houbraken, J. A. M. P., Lombardi, L., Garcia‐Rubio, R., Jenks, J. D., Rivero-Menéndez, O., Aljohani, R., Jacobsen, I. D., Berman, J. G., et al. (2021) · Studies in Mycology · doi:10.1016/j.simyco.2021.100115 · Cited by 262
Update on antifungal resistance in Aspergillus and Candida
Arendrup, M. C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12513 · Cited by 240
Genes y moléculas implicados en la virulencia de Aspergillus fumigatus
Rementerı́a, A., López-Molina, N., Ludwig, A., Vivanco, A. B., Bikandi, J., Pontón, J., & Garaizar, J. (2005) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(05)70001-2 · Cited by 237
Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene
Lockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J., & Balajee, S. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-11 · Cited by 232
Phylogenetic analysis of fungal ABC transporters
Kovalchuk, A., & Driessen, A. J. M. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-177 · Cited by 235
Substitutions at Methionine 220 in the 14α-Sterol Demethylase (Cyp51A) of Aspergillus fumigatus Are Responsible for Resistance In Vitro to Azole Antifungal Drugs
Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2747-2750.2004 · Cited by 210
Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing
Camps, S. M. T., Dutilh, B. E., Arendrup, M. C., Rijs, A. J. M. M., Snelders, E., Huynen, M. A., Verweij, P. E., & Melchers, W. J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050034 · Cited by 213
Resistance to antifungals that target CYP51
Parker, J. E., Warrilow, A. G. S., Price, C. L., Mullins, J. G. L., Kelly, D. E., & Kelly, S. L. (2014) · Journal of Chemical Biology · doi:10.1007/s12154-014-0121-1 · Cited by 217
Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology Modeling
Snelders, E., Karawajczyk, A., Schaftenaar, G., Verweij, P. E., & Melchers, W. J. G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01599-09 · Cited by 206
Acquired antifungal drug resistance inAspergillus fumigatus:epidemiology and detection
Howard, S. J., & Arendrup, M. C. (2010) · Medical Mycology · doi:10.3109/13693786.2010.508469 · Cited by 204
Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma
Chen, J., Li, H., Li, R., Bu, D., & Wan, Z. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh507 · Cited by 196
Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance
Alcázar‐Fuoli, L., & Mellado, E. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00439 · Cited by 187
Multidrug Resistance in Fungi
Gulshan, K., & Moye-Rowley, S. (2007) · Eukaryotic Cell · doi:10.1128/ec.00254-07 · Cited by 193
Multidrug Resistance in Yeast Candida
Prasad, R., & Kapoor, K. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42005-1 · Cited by 182
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F. G. M., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 186
Resistance of human fungal pathogens to antifungal drugs
Sanglard, D. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00344-2 · Cited by 178
Self-citation
Azole resistance mechanisms in Aspergillus: update and recent advances
Pérez‐Cantero, A., López‐Fernández, L., Guarro, J., & Capilla, J. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.011 · Cited by 185
Update on Antifungal Drug Resistance
Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 181
Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole
Ferreira, M. E. D. S., Malavazi, I., Savoldi, M., Brakhage, A. A., Goldman, M. H. S., Kim, H. S., Nierman, W. C., & Goldman, G. H. (2006) · Current Genetics · doi:10.1007/s00294-006-0073-2 · Cited by 159
The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus
Da Silva Ferreira, M. E., Colombo, A. L., Paulsen, I., Ren, Q., Wortman, J., Huang, J., Goldman, M. H. S., & Goldman, G. H. (2005) · Medical Mycology · doi:10.1080/13693780400029114 · Cited by 158
A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions
Hagiwara, D., Miura, D., Shimizu, K., Paul, S., Ohba, A., Gonoi, T., Watanabe, A., Kamei, K., Shintani, T., Moye-Rowley, W. S., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006096 · Cited by 156
Triazole Resistance in Aspergillus Species: An Emerging Problem
Garcia‐Rubio, R., Cuenca‐Estrella, M., & Mellado, E. (2017) · Drugs · doi:10.1007/s40265-017-0714-4 · Cited by 162
In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance
Ferreira, M. E. D. S., Capellaro, J. L., Marques, E. D. R., Malavazi, I., Perlin, D. S., Park, S., Anderson, J. B., Colombo, A. L., Arthington, B. A., Goldman, M. H. S., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4405-4413.2004 · Cited by 147
Triazole Resistance in Aspergillus spp.: A Worldwide Problem?
Rivero-Menendez, O., Alastruey-Izquierdo, A., Mellado, E., & Cuenca-Estrella, M. (2016) · Journal of Fungi · doi:10.3390/jof2030021 · Cited by 142
Multidrug resistance in fungi: regulation of transporter-encoding gene expression
Paul, S., & Moye-Rowley, W. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00143 · Cited by 137
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus
Chamilos, G., & Kontoyiannis, D. P. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2006.01.001 · Cited by 137
Exploring Azole Antifungal Drug Resistance in Aspergillus fumigatus with Special Reference to Resistance Mechanisms
Chowdhary, A., Sharma, C., Hagen, F., & Meis, J. F. G. M. (2014) · Future Microbiology · doi:10.2217/fmb.14.27 · Cited by 132
cyp51A -Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany
Bader, O., Weig, M., Reichard, U., Lugert, R., Kuhns, M., Christner, M., Held, J., Peter, S., Schumacher, U., Buchheidt, D., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00167-13 · Cited by 130
Biofilm formation byAspergillus fumigatus
Kaur, S., & Singh, S. (2013) · Medical Mycology · doi:10.3109/13693786.2013.819592 · Cited by 128
Antifungal drug resistance mechanisms
Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 121
Global Transcriptome Changes Underlying Colony Growth in the Opportunistic Human Pathogen Aspergillus fumigatus
Gibbons, J. G., Beauvais, A., Beau, R., McGary, K. L., Latgé, J., & Rokas, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05102-11 · Cited by 115
Essential Letters in the Fungal Alphabet
Perlin, M. H., Andrews, J. M., & Toh, S. S. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800271-1.00004-4 · Cited by 110
Drug Strategies Targeting CYP51 in Neglected Tropical Diseases
Choi, J. Y., Podust, L. M., & Roush, W. R. (2014) · Chemical Reviews · doi:10.1021/cr5003134 · Cited by 110
Rapid Detection of Triazole Antifungal Resistance in Aspergillus fumigatus
García‐Effrón, G., Dilger, A., Alcázar‐Fuoli, L., Park, S., Mellado, E., & Perlin, D. S. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02330-07 · Cited by 102
Elucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 103
Azole Resistance In Aspergillus Fumigatus : A New Challenge In The Management Of Invasive Aspergillosis?
Snelders, E., Melchers, W. J. G., & Verweij, P. E. (2011) · Future Microbiology · doi:10.2217/fmb.11.4 · Cited by 98
Interrogation of Related Clinical Pan-Azole-Resistant Aspergillus fumigatus Strains: G138C, Y431C, and G434C Single Nucleotide Polymorphisms incyp51A, Upregulation ofcyp51A, and Integration and Activation of TransposonAtf1in thecyp51APromoter
Albarrag, A., Anderson, M. J., Howard, S. J., Robson, G., Warn, P. A., Sanglard, D., & Denning, D. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-11 · Cited by 94
Self-citation
Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles
Pfaller, M., Boyken, L., Hollis, R., Kroeger, J., Messer, S., Tendolkar, S., & Diekema, D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02136-10 · Cited by 91
An update on ABC transporters of filamentous fungi – from physiological substrates to xenobiotics
Víglaš, J., & Olejníková, P. (2021) · Microbiological Research · doi:10.1016/j.micres.2020.126684 · Cited by 97
Contributions of Aspergillus fumigatus ATP-Binding Cassette Transporter Proteins to Drug Resistance and Virulence
Paul, S. K., Diekema, D. J., & Moye-Rowley, S. (2013) · Eukaryotic Cell · doi:10.1128/ec.00171-13 · Cited by 91
Azole resistant Aspergillus fumigatus: An emerging problem
Lelièvre, L., Groh, M., Angebault, C., Maherault, A.-C., Didier, E., & Bougnoux, M. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.02.010 · Cited by 90
Passive Surveillance for Azole-ResistantAspergillus fumigatus, United States, 2011–2013
Pham, C. D., Reiss, E., Hagen, F., Meis, J. F. G. M., & Lockhart, S. R. (2014) · Emerging infectious diseases · doi:10.3201/eid2009.140142 · Cited by 88
Mitochondrial dysfunctions trigger the calcium signaling-dependent fungal multidrug resistance
Li, Y., Zhang, Y., Zhang, C., Wang, H., Wei, X., Chen, P., & Lü, L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911560116 · Cited by 87
Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan
Tashiro, M., Izumikawa, K., Minematsu, A., Hirano, K., Iwanaga, N., Ide, S., Mihara, T., Hosogaya, N., Takazono, T., Morinaga, Y., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05394-11 · Cited by 87
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82
Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis
Campoli, P., Abdallah, Q. A., Robitaille, R., Solis, N. V., Fielhaber, J. A., Kristof, A. S., Laverdière, M., Filler, S. G., & Sheppard, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00637-11 · Cited by 77
Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance
Meneau, I., Coste, A. T., & Sanglard, D. (2016) · Medical Mycology · doi:10.1093/mmy/myw005 · Cited by 80
Self-citation
In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis
Ballard, E., Melchers, W. J. G., Zoll, J., Brown, A. J. P., Verweij, P. E., & Warris, A. (2018) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2018.02.003 · Cited by 76
Mechanisms of triazole resistance in Aspergillus fumigatus
Nywening, A. V., Rybak, J. M., Rogers, P. D., & Fortwendel, J. R. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15274 · Cited by 76
High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Nabili, M., Shokohi, T., Moazeni, M., Khodavaisy, S., Aliyali, M., Badiee, P., Zarrinfar, H., Hagen, F., & Badali, H. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000255 · Cited by 74
Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus
Cuenca‐Estrella, M., Gómez‐López, A., García‐Effrón, G., Alcázar‐Fuoli, L., Mellado, E., Buitrago, M. J., & Rodrı́guez-Tudela, J. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1232-1235.2005 · Cited by 71
Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates
Dilmaghanian, S., Gerber, J. G., Filler, S. G., Sanchez, A. A., & Gal, J. (2003) · Chirality · doi:10.1002/chir.10294 · Cited by 69
Aspergillosis, Avian Species and the One Health Perspective: The Possible Importance of Birds in Azole Resistance
Melo, A. M., Stevens, D. A., Tell, L. A., Veríssimo, C., Sabino, R., & Xavier, M. O. (2020) · Microorganisms · doi:10.3390/microorganisms8122037 · Cited by 68
Azole-Resistant Invasive Aspergillosis: Relationship to Agriculture
Stensvold, C. R., Jørgensen, L. N., & Arendrup, M. C. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0097-7 · Cited by 75
Medically Important Fungi Respond to Azole Drugs: An Update
Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 64
Does agricultural use of azole fungicides contribute to resistance in the human pathogen Aspergillus fumigatus ?
Hollomon, D. (2017) · Pest Management Science · doi:10.1002/ps.4607 · Cited by 57
Aspergillus fumigatus C-5 Sterol Desaturases Erg3A and Erg3B: Role in Sterol Biosynthesis and Antifungal Drug Susceptibility
Alcázar‐Fuoli, L., Mellado, E., García‐Effrón, G., Buitrago, M. J., López, J. F., Grimalt, J. O., Cuenca-Estrella, J. M., & Rodrı́guez-Tudela, J. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.453-460.2006 · Cited by 59
Cholesterol Import by Aspergillus fumigatus and Its Influence on Antifungal Potency of Sterol Biosynthesis Inhibitors
Xiong, Q., Hassan, S. A., Wilson, W. K., Han, X. Y., May, G. S., Tarrand, J. J., & Matsuda, S. P. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.518-524.2005 · Cited by 56
Genome‐wide identification of target genes of a mating‐type α‐domain transcription factor reveals functions beyond sexual development
Becker, K., Beer, C., Freitag, M., & Kück, U. (2015) · Molecular Microbiology · doi:10.1111/mmi.12987 · Cited by 60
Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations
Sharma, C., Sathi, S. N., Singh, A. K., Pillai, M. R., & Chowdhary, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103265 · Cited by 56
Transcriptomic and Proteomic Profile of Aspergillus fumigatus on Exposure to Artemisinin
Gautam, P., Upadhyay, S. K., Hassan, W., Madan, T., Sirdeshmukh, R., Sundaram, C. S., Gade, W. N., Basir, S. F., Singh, Y. P., & Sarma, P. U. (2011) · Mycopathologia · doi:10.1007/s11046-011-9445-3 · Cited by 54
Pharmacology and clinical use of voriconazole
Thompson, G. R., & Lewis, J. S. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903463878 · Cited by 52
Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification
Perlin, D. S., & Wiederhold, N. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix121 · Cited by 51
Analysis of a nonribosomal peptide synthetase gene from Alternaria brassicae and flanking genomic sequences
Guillemette, T., Sellam, A., & Simoneau, P. (2004) · Current Genetics · doi:10.1007/s00294-003-0479-z · Cited by 49
Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus
Moye-Rowley, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00070 · Cited by 50
Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan
Wang, H., Huang, J., Lin, Y., Chen, Y., Hsieh, M., Choi, P., Lo, H., Liu, W., Hsu, C., Shih, H., et al. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13988 · Cited by 49
Emerging fungal resistance
Baddley, J. W., & Moser, S. A. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.05.003 · Cited by 47
Azole Antifungal Resistance Today: Focus on Aspergillus
Bowyer, P., Moore, C. B., Rautemaa, R., Denning, D. W., & Richardson, M. D. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0218-4 · Cited by 44
Self-citation
Emerging Mechanisms of Drug Resistance in Candida albicans
Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 44
New resistance mechanisms to azole drugs inAspergillus fumigatusand emergence of antifungal drugs-resistantA. fumigatusatypical strains
Mellado, E., Alcázar‐Fuoli, L., García‐Effrón, G., Alastruey‐Izquierdo, A., Cuenca‐Estrella, M., & Rodríguez-Tudela, J. L. (2006) · Medical Mycology · doi:10.1080/13693780600902243 · Cited by 43
Host-Pathogen Interactions Mediated by MDR Transporters in Fungi: As Pleiotropic as it Gets!
Cavalheiro, M., Pais, P., Galocha, M., & Teixeira, M. C. (2018) · Genes · doi:10.3390/genes9070332 · Cited by 44
Exploring the molecular mechanism of azole resistance in Aspergillus fumigatus
Chen, P., Liu, J., Zeng, M., & Sang, H. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100915 · Cited by 44
Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus
Bowyer, P., Mosquera, J., Anderson, M. J., Birch, M., Bromley, M., & Denning, D. W. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02575.x · Cited by 41
Self-citation
Genome-scale analysis of ABC transporter genes and characterization of the ABCC type transporter genes in Magnaporthe oryzae
Kim, Y., Park, S., Kim, D., Choi, J., Lee, Y., Lee, J., & Choi, W. (2013) · Genomics · doi:10.1016/j.ygeno.2013.04.003 · Cited by 40
Genome-Wide Association and Selective Sweep Studies Reveal the Complex Genetic Architecture of DMI Fungicide Resistance in Cercospora beticola
Spanner, R., Taliadoros, D., Richards, J. K., Rivera-Varas, V. V., Neubauer, J. D., Natwick, M. B., Hamilton, O., Vaghefi, N., Pethybridge, S. J., Secor, G. A., et al. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab209 · Cited by 42
Investigating the role of ABC transporters in multifungicide insensitivity in Phytophthora infestans
Judelson, H. S., & Senthil, G. (2005) · Molecular Plant Pathology · doi:10.1111/j.1364-3703.2004.00256.x-i1 · Cited by 39
Yeast ABC proteins involved in multidrug resistance
Piecuch, A., & Obłąk, E. (2013) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-013-0111-2 · Cited by 38
Characterization of the Efflux Capability and Substrate Specificity of Aspergillus fumigatus PDR5-like ABC Transporters Expressed in Saccharomyces cerevisiae
Esquivel, B. D., Rybak, J. M., Barker, K. S., Fortwendel, J. R., Rogers, P. D., & White, T. C. (2020) · mBio · doi:10.1128/mbio.00338-20 · Cited by 35
Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus
Natesan, S. K., Lamichchane, A. K., Swaminathan, S., & Wu, W. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.04.022 · Cited by 34
Resistance to antifungal therapies
Prasad, R., Banerjee, A., & Shah, A. H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160067 · Cited by 33

Authors: Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., & Denning, D. W.
Affiliations: University of Manchester (GB)
Centre Hospitalier Universitaire Vaudois (CH)
AstraZeneca (United Kingdom) (GB)
Corresponding author: Denning, David W
ORCID: Anderson, Michael J
Sanglard, Dominique
Roberts, Ian S
Denning, David W
Venue: Fungal Genetics and Biology
Publisher: Elsevier BV
Published: 2002-08
Volume: 36
Issue: 3
Pages: 199-206
ISSN: 1087-1845 (ISSN-L)
DOI: 10.1016/s1087-1845(02)00016-6
OpenAlex: W2097302864
Cited by: 202
References: 45
Citations by year: 2026: 11 · 2025: 8 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 7 · 2017: 14 · 2016: 12 · 2015: 8 · 2014: 14 · 2013: 12 · 2012: 7
FWCI: 4.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Fungal Genetics and Biology (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Funders: Medical Research Council
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: Aspergillus fumigatus, ABC transporters, itraconazole resistance, drug efflux, multidrug resistance, gene overexpression, invasive aspergillosis, antifungal resistance
MeSH terms: Amino Acid Sequence, Antifungal Agents, Aspergillus fumigatus, Base Sequence, Cloning, Molecular, Drug Resistance, Microbial, Microbial Sensitivity Tests, Molecular Sequence Data, Immunoblotting, Gene Expression Regulation, Fungal, Itraconazole, ATP-Binding Cassette Transporters

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks